CHR. OLESEN SYNTHESIS A/S: Financial statements 2020
CVR: 33964870
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
CHR. OLESEN SYNTHESIS A/S (CVR 33964870) has filed annual accounts for 2020. In 2020, the company reported a gross profit of EUR 1,381,141 and a net result of EUR -3,272,955 compared with EUR -3,060,469 the year before. That is a decrease of 20.3% compared with the year before. Equity in the 2020 report amounted to EUR -6,315,585. The company had 49 employees in the financial year.
- Gross Profit
- EUR 1,381,141
- Profit/Loss
- EUR -3,272,955
- Equity
- EUR -6,315,585
- Total Assets
- EUR 12,313,378
- Employees
- 49
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.4M EUR | -3.3M EUR | -6.3M EUR | 49 |
| 2019 | - | 1.7M EUR | -3.1M EUR | -3M EUR | 49 |
| 2018 | - | 267K EUR | -3.6M EUR | 1.5M EUR | 43 |
| 2017 | - | 1.2M EUR | -2.3M EUR | 5.1M EUR | 42 |
| 2016 | - | -502K EUR | -3.2M EUR | 7.4M EUR | - |
Official annual report
How creditworthy is CHR. OLESEN SYNTHESIS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CHR. OLESEN SYNTHESIS A/S has published its annual report for 2019. Gross profit came to DKK 1,732,625, and the net result was DKK -3,060,469.
About CHR. OLESEN SYNTHESIS A/S
CHR. OLESEN SYNTHESIS A/S is a Danish company of the type Aktieselskab based in Hvidovre, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Thomas Michael Moestrup. The board consists of Jean-Francois Hilaire (chair), Joseph Nivaro and Thomas Michael Moestrup. The company is owned by Samfara/Bering Bidco Limited. The company has 97 employees (2026). In 2025, the company reported a gross profit of EUR 6,958,825 and a net result of EUR -2,299,046 compared with EUR 7,391,800 the year before. Equity in the 2025 report amounted to EUR -9,489,900.
